Cite
HARVARD Citation
Thang, S. et al. (2020). Clinical outcomes of 177lutetium-prostate-specific membrane antigen therapy in advanced prostate cancer—a prospective pilot study in an Asian population. Nuclear medicine communications. 41 (7), p. . [Online].